2,6-Dimethoxyquinone

CAS No. 530-55-2

2,6-Dimethoxyquinone( —— )

Catalog No. M18744 CAS No. 530-55-2

2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 27 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2,6-Dimethoxyquinone
  • Note
    Research use only, not for human use.
  • Brief Description
    2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones.
  • Description
    2, 6-dimethoxy-1, 4-benzoquinone is a member of the class of compounds known as P-benzoquinones. 2, 6-dimethoxy-1, 4-benzoquinone is slightly soluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). It is a benzoquinone, a chemical compound found in Rauvolfia vomitoria, in Tibouchina pulchra, and in common wheat.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    530-55-2
  • Formula Weight
    168.15
  • Molecular Formula
    C8H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5.56 mg/mL (33.07 mM)
  • SMILES
    O=C1C(=CC(=O)C=C1OC)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Naringin

    Naringin is a flavanone glycoside, which exerts a variety of pharmacological effects such as antioxidant activity, blood lipid lowering, anticancer activity, and inhibition of cytochrome P450 enzymes.

  • CYP1B1-IN-5

    CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.

  • Anemosapogenin

    Anemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.